Michael W. Drazer

1.6k total citations
38 papers, 769 citations indexed

About

Michael W. Drazer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael W. Drazer has authored 38 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 12 papers in Public Health, Environmental and Occupational Health and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael W. Drazer's work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cancer Genomics and Diagnostics (8 papers). Michael W. Drazer is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cancer Genomics and Diagnostics (8 papers). Michael W. Drazer collaborates with scholars based in United States, Canada and Israel. Michael W. Drazer's co-authors include Scott E. Eggener, Dezheng Huo, Lucy A. Godley, Gautam Jayram, Simone Feurstein, Mara A. Schonberg, Scott Eggener, Aria Razmaria, Gregory W. Roloff and Jane E. Churpek and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael W. Drazer

30 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W. Drazer United States 15 278 210 192 181 123 38 769
Jacques Olivier Bay France 12 203 0.7× 115 0.5× 201 1.0× 60 0.3× 43 0.3× 30 474
Jeffrey Schneider United States 15 160 0.6× 139 0.7× 592 3.1× 120 0.7× 58 0.5× 40 882
Merlın Hamre United States 18 303 1.1× 48 0.2× 425 2.2× 201 1.1× 209 1.7× 29 1.1k
Rudolf Weide Germany 19 236 0.8× 198 0.9× 488 2.5× 68 0.4× 63 0.5× 89 1.0k
P Carli France 6 212 0.8× 60 0.3× 469 2.4× 224 1.2× 61 0.5× 14 917
Akthar Shamsaldin France 11 216 0.8× 119 0.6× 227 1.2× 62 0.3× 153 1.2× 11 768
Tomoko Tamaki Japan 9 124 0.4× 159 0.8× 123 0.6× 79 0.4× 85 0.7× 26 566
Kjell Bergfeldt Sweden 16 175 0.6× 93 0.4× 337 1.8× 331 1.8× 125 1.0× 28 1.1k
AA Bartolucci United States 12 166 0.6× 165 0.8× 242 1.3× 222 1.2× 154 1.3× 20 861
D.J. van Spronsen Netherlands 20 209 0.8× 55 0.3× 403 2.1× 106 0.6× 67 0.5× 36 856

Countries citing papers authored by Michael W. Drazer

Since Specialization
Citations

This map shows the geographic impact of Michael W. Drazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Drazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Drazer more than expected).

Fields of papers citing papers by Michael W. Drazer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Drazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Drazer. The network helps show where Michael W. Drazer may publish in the future.

Co-authorship network of co-authors of Michael W. Drazer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Drazer. A scholar is included among the top collaborators of Michael W. Drazer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Drazer. Michael W. Drazer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wahlster, Lara, Lucy A. Godley, Jason X. Cheng, et al.. (2025). ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. Blood. 146(2). 254–259.
2.
Kindler, Hedy L., Ibiayi Dagogo‐Jack, Marc de Perrot, et al.. (2025). Treatment of Pleural Mesothelioma: ASCO Guideline Clinical Insights. JCO Oncology Practice. 21(10). 1413–1416.
3.
Stubbins, Ryan J., Stephen Arnovitz, Imo J. Akpan, et al.. (2025). Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants. Leukemia. 39(7). 1702–1713.
4.
Roloff, Gregory W., Satyajit Kosuri, Adam DuVall, et al.. (2024). Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation. Haematologica. 109(11). 3739–3744. 1 indexed citations
5.
Wahlster, Lara, Jared H. Rowe, Nina Weichert‐Leahey, et al.. (2024). Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series. Blood. 144(Supplement 1). 5708–5708.
6.
7.
8.
Ong, Cecilia T., Yaniv Berger, Biren Reddy, et al.. (2024). Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk. Annals of Surgical Oncology. 31(5). 3339–3349. 1 indexed citations
9.
Roloff, Gregory W., et al.. (2023). Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes. Leukemia & lymphoma. 64(9). 1562–1565. 3 indexed citations
10.
Roloff, Gregory W., et al.. (2023). Stagnation in quality of next‐generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies. Journal of Genetic Counseling. 32(3). 744–749. 4 indexed citations
11.
Berger, Yaniv, Heather Chen, Oliver S. Eng, et al.. (2023). Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation. Cancer. 129(14). 2152–2160. 2 indexed citations
12.
Pavani, Giulia, Jean Ann Maguire, Rodney M. Camire, et al.. (2021). Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Reports. 16(6). 1458–1467. 14 indexed citations
13.
White, Michael G., et al.. (2021). Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient. Journal of Gastrointestinal Surgery. 25(12). 3258–3264. 14 indexed citations
14.
Roloff, Gregory W., Lucy A. Godley, & Michael W. Drazer. (2020). Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies. Genetics in Medicine. 23(1). 211–214. 17 indexed citations
15.
Akpan, Imo J., Afaf E.G. Osman, Michael W. Drazer, & Lucy A. Godley. (2018). Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies. Current Hematologic Malignancy Reports. 13(6). 426–434. 9 indexed citations
16.
Tawana, Kiran, Michael W. Drazer, & Jane E. Churpek. (2018). Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?. Leukemia. 32(7). 1482–1492. 36 indexed citations
17.
Feurstein, Simone, Michael W. Drazer, & Lucy A. Godley. (2016). Genetic predisposition to leukemia and other hematologic malignancies. Seminars in Oncology. 43(5). 598–608. 43 indexed citations
18.
Drazer, Michael W. & Walter M. Stadler. (2016). The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer. The Cancer Journal. 22(5). 330–333. 8 indexed citations
19.
Jayram, Gautam, et al.. (2011). Global Trends in Testicular Cancer Incidence and Mortality. European Urology. 60(2). 374–379. 103 indexed citations
20.
Ybe, Joel A., et al.. (2007). Light Chain C‐Terminal Region Reinforces the Stability of Clathrin Heavy Chain Trimers. Traffic. 8(8). 1101–1110. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Olivier Bay Breakdown of academic impact, for papers by Jeffrey Schneider Breakdown of academic impact, for papers by Merlın Hamre Breakdown of academic impact, for papers by Rudolf Weide Breakdown of academic impact, for papers by P Carli Breakdown of academic impact, for papers by Akthar Shamsaldin Breakdown of academic impact, for papers by Tomoko Tamaki Breakdown of academic impact, for papers by Kjell Bergfeldt Breakdown of academic impact, for papers by AA Bartolucci Breakdown of academic impact, for papers by D.J. van Spronsen
Rankless by CCL
2026